These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

161 related articles for article (PubMed ID: 5068520)

  • 21. [Surfactant and its role in the pathogenesis of lung diseases (a review of the literature)].
    Alatyrtseva SG; Pukhovskaia NV
    Vopr Okhr Materin Det; 1973 Oct; 18(10):51-5. PubMed ID: 4594381
    [No Abstract]   [Full Text] [Related]  

  • 22. [Velocity of the pulse wave spread in patients with chronic nonspecific diseases of the lungs].
    Berezhnitskiĭ MN
    Vrach Delo; 1968 Sep; 9():12-4. PubMed ID: 5740292
    [No Abstract]   [Full Text] [Related]  

  • 23. Pulmonary complications of oxygen therapy in the neonate. Postmortem study of bronchopulmonary dysplasia with emphasis on fibroproliferative obliterative bronchitis and bronchiolitis.
    Anderson WR; Strickland MB
    Arch Pathol; 1971 Jun; 91(6):506-14. PubMed ID: 5577034
    [No Abstract]   [Full Text] [Related]  

  • 24. [Surface tension and surfactant anti-atelectasis factor in the lung tissue (a review)].
    Traczyk K
    Gruzlica; 1969 Jun; 37(6):565-72. PubMed ID: 4900500
    [No Abstract]   [Full Text] [Related]  

  • 25. ["Surfactant": the surface film of pulmonary alveoli].
    Gil J
    Schweiz Med Wochenschr; 1968 Aug; 98(35):1338-42. PubMed ID: 4879930
    [No Abstract]   [Full Text] [Related]  

  • 26. [Pulmonary atelectasis (pathological anatomy and pathogenesis)].
    Esipova IK; Evsegneeva MV
    Sov Med; 1982; (8):68-73. PubMed ID: 6897301
    [No Abstract]   [Full Text] [Related]  

  • 27. [Morphology of pulmonary atelectasis in patients operated on and not operated on taking into account pulmonary surfactant state].
    Magomedov MK; Titova GP; Barinova MV
    Arkh Patol; 1979; 41(11):57-64. PubMed ID: 583209
    [TBL] [Abstract][Full Text] [Related]  

  • 28. [Presence of the surfactant system in the lung as a condition for recovery from upper respiratory tract diseases. II. Origin of the surfactant system].
    Wildeboer-Venema FN
    Ned Tijdschr Geneeskd; 1971 Sep; 115(36):1494-7. PubMed ID: 5109315
    [No Abstract]   [Full Text] [Related]  

  • 29. [Atelectasis--instability of the pulmonary alveolus based on surface chemistry].
    Yoshida S
    Kokyu To Junkan; 1973 Mar; 21(3):192-200. PubMed ID: 4571149
    [No Abstract]   [Full Text] [Related]  

  • 30. [Variations of the elasticity and distensibility of rat lung caused by administration of some drugs and considerations on the technic of the pulmonary tension-volume curve and the modifications obtained in different experimental pathological conditions].
    Cornia G; Mannino F
    Ann Ist Carlo Forlanini; 1969; 29(3):239-51. PubMed ID: 5409300
    [No Abstract]   [Full Text] [Related]  

  • 31. Diagnostic lung biopsy: a correlative determination of histopathology and pulmonary surfactant.
    Thomas PA
    Am Rev Respir Dis; 1967 Dec; 96(6):1222-8. PubMed ID: 6057624
    [No Abstract]   [Full Text] [Related]  

  • 32. [CHRONIC NON-TUBERCULOUS PNEUMOPHATHIES].
    MATTE R; IBANEZ S; BUSTAMANTE W; GARCIA M
    Rev Chil Pediatr; 1964 Jun; 35():492-500. PubMed ID: 14212620
    [No Abstract]   [Full Text] [Related]  

  • 33. Surfactant in chronic smokers.
    Cook WA; Webb WR
    Ann Thorac Surg; 1966 May; 2(3):327-33. PubMed ID: 5954467
    [No Abstract]   [Full Text] [Related]  

  • 34. [Presence of the surfactant system in the lung as a condition for recovery from upper respiratory tract diseases. I. Introduction].
    Wildeboer-Venema FN
    Ned Tijdschr Geneeskd; 1971 Aug; 115(35):1455-9. PubMed ID: 5109314
    [No Abstract]   [Full Text] [Related]  

  • 35. [Diagnostic value and significance of BALF cell analysis in patients with pulmonary diseases].
    Mikami M; Amaya M; Mitsuhashi Y; Ozasa K; Suzuki A
    Nihon Kyobu Shikkan Gakkai Zasshi; 1987 Jan; 25(1):99-105. PubMed ID: 3599587
    [No Abstract]   [Full Text] [Related]  

  • 36. [On congenital alveolar dysplasia].
    Plank J
    Gegenbaurs Morphol Jahrb; 1967; 111(2):258-64. PubMed ID: 5588139
    [No Abstract]   [Full Text] [Related]  

  • 37. [Heart- and vascular changes in lung diseases. I. Pathology].
    Kühne W
    Z Erkr Atmungsorgane Folia Bronchol; 1973-1974; 139(2):153-66. PubMed ID: 4603570
    [No Abstract]   [Full Text] [Related]  

  • 38. [Effect of preoperative preparation on the state of the surfactant in chronic pneumonia].
    Panevskaia GN; Alekseenko AV; Nesterov EN
    Vestn Khir Im I I Grek; 1979 Jun; 122(6):35-8. PubMed ID: 582220
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Evidence of active alveolar closure in the human lung.
    Emmanuel GE; Rosenbluth A; Ansari I; Villano R; Carducci R
    Aspen Emphysema Conf; 1968; 11():287-96. PubMed ID: 5711552
    [No Abstract]   [Full Text] [Related]  

  • 40. [Reproducibility of treadmill exercise tests in patients with chronic lung disease].
    Kurihara N; Terakawa K; Fujimoto S
    Kokyu To Junkan; 1982 Aug; 30(8):795-802. PubMed ID: 7134686
    [No Abstract]   [Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 9.